Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateNew HampshireIn Committee
HB 1638: creating a bypass mechanism for health insurer step therapy protocols when medically necessary.
Dave Nagel
HB 1638 status: In Committee — Subcommittee Work Session: 10/07/2026 10:00 am GP 229 (updated Sep 17, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
74OUT OF 100
Score:74/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 60/100
Constitutionality95%
Bipartisan90%
Public opinion85%
Bill summary
Right now, many insurance companies force you to try cheaper, older drugs before they will pay for the medicine your doctor actually prescribed. This bill would create a way to "skip" that requirement when a doctor proves you medically need the specific medicine right away. It is currently being reviewed in the House.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
45%
Benefits
- Reduced administrative burden for medical practices due to standardized exceptions
- Improved patient health outcomes leading to better long-term productivity
- Clearer statutory framework for insurance utilization review
Risks
- Increased insurance premiums due to higher utilization of expensive drugs
- Added administrative overhead for health insurance carriers
- Potential for cost-shifting to employers and municipalities
Society
Positive outlook
80%
Benefits
- Faster access to prescribed medications for patients
- Clearer pathways for mental health treatment coverage
- Protection for patients currently stable on effective drugs
Risks
- Potential for patients to encounter denial of requested exceptions
- Requirement for providers to manage additional documentation
- Possible delays during the appeal process for overrides
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Positive outlook
85%
Benefits
- Mandatory public review and comment for clinical guidelines
- Defined statutory response timelines for carriers
- Requirements for conflict-of-interest disclosure by experts
Risks
- Limited citizen ability to influence private carrier policies
- Complexity of enforcing compliance across multiple carriers
- Burden of Insurance Department in monitoring carrier audits
Public Health & Safety
Positive outlook
85%
Benefits
- Safety overrides for contraindicated or harmful drug interactions
- Mandatory expedited review for urgent clinical circumstances
- Protection for metastatic cancer patients from restrictive protocols
Risks
- Risk of clinical delay if override requests are initially denied
- Challenges in defining atypical populations for clinical criteria
- Potential reliance on imperfect peer-reviewed guidelines
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
May lead to premium increases due to higher drug utilization costs.
Analysis scope
Economic impact is indeterminable based on current fiscal note analysis.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.